Trials / Completed
CompletedNCT00663325
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower
Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Tangerina Mix
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 10 Years – 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactic acid (Dermacid) | Liquid soup to be applied in the external genital area, in a small quantity, with abundantly rinse after use, during 21 days. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-01-01
- First posted
- 2008-04-22
- Last updated
- 2009-01-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00663325. Inclusion in this directory is not an endorsement.